Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The role of autophagy in squamous cell carcinoma of the head and neck.

Cosway B, Lovat P.

Oral Oncol. 2016 Mar;54:1-6. doi: 10.1016/j.oraloncology.2015.12.007. Epub 2016 Jan 7. Review.

PMID:
26774913
2.

[The relationship between lysosome-autophagy and the head and neck squamous cancer cell apoptosis].

Qu QQ, Zhang SW, Li XJ.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Dec;30(24):1975-1979. doi: 10.13201/j.issn.1001-1781.2016.24.022. Review. Chinese.

PMID:
29798282
3.

Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.

Gunawardena I, Arendse M, Jameson MB, Plank LD, Gregor RT.

ANZ J Surg. 2015 Nov;85(11):843-8. doi: 10.1111/ans.12424. Epub 2013 Oct 31.

PMID:
24171785
4.

MED15: a potential biomarker for head and neck squamous cell carcinoma?

Offermann A, Shaikhibrahim Z, Perner S.

Biomark Med. 2015;9(10):939-41. doi: 10.2217/bmm.15.57. Epub 2015 Oct 12. No abstract available.

5.

New biological markers in the decision of treatment of head and neck cancer patients.

Valenciano A, Henríquez-Hernández LA, Lloret M, Pinar B, Lara PC.

Clin Transl Oncol. 2014 Oct;16(10):849-58. doi: 10.1007/s12094-014-1193-7. Epub 2014 Jul 1. Review.

PMID:
24981589
6.

[The role of microRNAs in head and neck squamous cell carcinoma : Biomarkers for prognosis, therapy selection, and novel therapeutics].

Heß AK, Weichert W, Budach V, Tinhofer I.

HNO. 2016 May;64(5):296-302. doi: 10.1007/s00106-015-0111-9. Review. German.

PMID:
26746640
7.

MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.

Wang Y, Wang J, Huang Y.

Cancer Biomark. 2015;15(3):213-8. doi: 10.3233/CBM-150464. Review.

PMID:
25769448
8.

DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.

Jelihovschi I, Bidescu AC, Tucaliuc SE, Iancu LS.

Rev Med Chir Soc Med Nat Iasi. 2015 Apr-Jun;119(2):502-9. Review.

PMID:
26204659
9.

Role of molecular markers and gene profiling in head and neck cancers.

Gold KA, Kim ES.

Curr Opin Oncol. 2009 May;21(3):206-11. doi: 10.1097/CCO.0b013e328329ac00. Review.

PMID:
19346943
10.

ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.

Patel MR, Zhao N, Ang MK, Stadler ME, Fritchie K, Weissler MC, Zanation AM, Harris SL, Funkhouser WK, Olshan AF, Shores CG, Hayes DN.

Otolaryngol Head Neck Surg. 2013 Oct;149(4):587-95. doi: 10.1177/0194599813496522. Epub 2013 Jul 11.

PMID:
23846458
11.

Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T.

Mol Cell Proteomics. 2012 Nov;11(11):1404-15. doi: 10.1074/mcp.M112.020933. Epub 2012 Aug 23.

12.

[Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].

Wittekindt C, Wagner S, Mayer CS, Klußmann JP.

Laryngorhinootologie. 2012 Mar;91 Suppl 1:S1-26. doi: 10.1055/s-0031-1297241. Epub 2012 Mar 28. Review. German.

PMID:
22456913
13.

Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.

Boscolo-Rizzo P, Rampazzo E, Perissinotto E, Piano MA, Giunco S, Baboci L, Spinato G, Spinato R, Tirelli G, Da Mosto MC, Del Mistro A, De Rossi A.

Oral Oncol. 2015 May;51(5):500-7. doi: 10.1016/j.oraloncology.2015.02.100. Epub 2015 Mar 11.

PMID:
25771075
14.

[Tumor markers and biomarkers in squamous cell cancer of the head and neck].

Lordick F, Krauss J, Jäger D.

HNO. 2008 Sep;56(9):881-5. doi: 10.1007/s00106-008-1762-6. Review. German.

PMID:
18696018
15.

Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.

Göke F, Bode M, Franzen A, Kirsten R, Goltz D, Göke A, Sharma R, Boehm D, Vogel W, Wagner P, Lengerke C, Kristiansen G, Kirfel J, Van Bremen T, Bootz F, Heasley LE, Schröck A, Perner S.

Mod Pathol. 2013 Oct;26(10):1298-306. doi: 10.1038/modpathol.2013.58. Epub 2013 Apr 26.

16.

Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.

Masand RP, El-Mofty SK, Ma XJ, Luo Y, Flanagan JJ, Lewis JS Jr.

Head Neck Pathol. 2011 Jun;5(2):108-16. doi: 10.1007/s12105-011-0245-3. Epub 2011 Feb 9. Review.

17.

Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.

Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R.

Oncotarget. 2015 Aug 7;6(22):18863-74.

18.

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.

Psyrri A, Rampias T, Vermorken JB.

Ann Oncol. 2014 Nov;25(11):2101-15. doi: 10.1093/annonc/mdu265. Epub 2014 Jul 23. Review.

PMID:
25057165
19.

Human papilloma virus: a new risk factor in a subset of head and neck cancers.

Bisht M, Bist SS.

J Cancer Res Ther. 2011 Jul-Sep;7(3):251-5. doi: 10.4103/0973-1482.87004. Review.

20.

NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells.

Sobhakumari A, Schickling BM, Love-Homan L, Raeburn A, Fletcher EV, Case AJ, Domann FE, Miller FJ Jr, Simons AL.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):736-45. doi: 10.1016/j.taap.2013.07.013. Epub 2013 Jul 31.

Supplemental Content

Support Center